Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013239
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials and preparations, bio-engineering drugs, and nutritious and health products. Its products include suxiao jiuxin wan, shunaoxin diwan, niuhuang jiangya xilie, longqing pian, jingwanhong,jingzhi yinqiao jiedu pian,niuhuang qingxin wan, and others. TZPG conducts research and development to develop new products. The company’s products are used to treat cardiovascular disease, cold, vomit, diarrhea, dyspepsia, chemotherapy, diabetes, hematosepsis, and pneumonia. It operates various technology centers. The company exports its products to Japan, Australia, the US, Canada, Russia, the Netherlands, Singapore, Indonesia, and Germany. TZPG is headquartered in Tianjin, China.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tianjin Zhongxin Pharma To Form Two Joint Ventures 10
Equity Offering 11
Tianjin Zhongxin Raises USD135.6 Million in Private Placement of Shares 11
Acquisition 13
Jiaxing Yun Shi Tai Yu Investment to Acquire 20% Stake in Tianjin Sinobioway Biomedicine from Tianjin Zhongxin Pharma 13
Tianjin Zhongxin Pharma to Acquire 20% Stake in Chinese Medicine Unit 14
Tianjin Lisheng To Acquire Tianjin Central Pharma For US$79.2 Million 15
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Competitors 16
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employees 17
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tianjin Zhongxin Pharma To Form Two Joint Ventures 10
Tianjin Zhongxin Raises USD135.6 Million in Private Placement of Shares 11
Jiaxing Yun Shi Tai Yu Investment to Acquire 20% Stake in Tianjin Sinobioway Biomedicine from Tianjin Zhongxin Pharma 13
Tianjin Zhongxin Pharma to Acquire 20% Stake in Chinese Medicine Unit 14
Tianjin Lisheng To Acquire Tianjin Central Pharma For US$79.2 Million 15
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Competitors 16
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employees 17

★海外企業調査レポート[Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Montefiore Medical Center-医療機器分野:企業M&A・提携分析
    Summary Montefiore Medical Center (MMC) is a healthcare service provider that offers clinical services. The center offers services such as allergy and immunology, orthopaedics, dentistry and oral surgery, dermatology, endocrinology, digestive and liver diseases, neurological surgery, otorhinolaryngo …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Taubman Centers Inc:企業の戦略的SWOT分析
    Taubman Centers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Siam Commercial Bank Public Company Limited:企業の戦略・SWOT・財務分析
    The Siam Commercial Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Siam Commercial Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • VertiFlex Inc:医療機器:M&Aディール及び事業提携情報
    Summary VertiFlex Inc (Vertiflex) is a medical device company that offers invasive treatments for lumbar stenosis. The company offers products such as interspinous spacer and direct decompression systems. Its interspinous spacer system is a motion-preserving, indirect decompression spinal implant sy …
  • Ferrovial SA (FER):企業の財務・戦略的SWOT分析
    Ferrovial SA (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • InSightec Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • Kilitch Drugs India Ltd (KILITCH):製薬・医療:M&Aディール及び事業提携情報
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as parenterals and nasal products, oral, effervesscent, nutritional products, medical device, …
  • Canadian Broadcasting Corp:企業の戦略的SWOT分析
    Canadian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It offers cosmeceutical programs such as development of anti-aging and depigmenting agents, …
  • The Seibels Bruce Group, Inc:企業の戦略・SWOT・財務情報
    The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Vale SA:企業のM&A・事業提携・投資動向
    Vale SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vale SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • St. Joseph Health:企業の戦略的SWOT分析
    St. Joseph Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PharmaCyte Biotech Inc (PMCB):企業の財務・戦略的SWOT分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • China National Electronics Import & Export Corporation:戦略・SWOT・企業財務分析
    China National Electronics Import & Export Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Electronics Import & Export Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報
    Summary Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management o …
  • Orkuveita Reykjavikur:電力:M&Aディール及び事業提携情報
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …
  • FireEye, Inc.:企業のM&A・事業提携・投資動向
    FireEye, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FireEye, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆